BioCritica, Inc. — Form D

BioCritica, Inc. of INDIANAPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2011-05-26. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2011-05-26
Form: D
Accession: 0001521626-11-000001
Industry: Pharmaceuticals
Exemptions: 06
Total offering: $25.0M
Amount sold: $25.0M
Investors: 4
Date of first sale: 2011-05-20
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-160380

Issuer

Name: BioCritica, Inc.
CIK: 0001521626
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2011
Address: 8888 KEYSTONE CROSSING, INDIANAPOLIS, IN, 46240
Phone: 317-575-4035

Officers, directors & promoters (10)

Name	Role	Location
MICHAEL J BOLOGNA	Director	RALEIGH, NC
David A Broecker	Director	Zionsville, IN
DARREN J CARROLL	Director	INDIANAPOLIS, IN
MIKE F JOHNSON	Director	INDIANAPOLIS, IN
ARGERIS N KARABELAS	Director	PRINCETON, NJ
Lorenzo N Pellegrini	Director	Princeton, NJ
Ronald J Wooten	Director	Raleigh, NC
David A Broecker	Executive Officer	Zionsville, IN
MICHAEL D PAGNOTTA	Executive Officer	INDIANAPOLIS, IN
MARK D WILLIAMS	Executive Officer	INDIANAPOLIS, IN

More